# Efficacy of Hydroxyzine for Patients With Panic Disorder

> **NCT05737511** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Sultan Qaboos University** · enrollment: 80 (estimated)

## Conditions studied

- Panic Disorder

## Interventions

- **DRUG:** Hydroxyzine
- **DRUG:** Escitalopram Oxalate

## Key facts

- **NCT ID:** NCT05737511
- **Lead sponsor:** Sultan Qaboos University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-12-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737511, "Efficacy of Hydroxyzine for Patients With Panic Disorder". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05737511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*